Ident. | Authors (with country if any) | Title |
---|
000362 (2014) |
J Vincent Filoteo [États-Unis] ; Jason D. Reed ; Irene Litvan ; Deborah L. Harrington | Volumetric correlates of cognitive functioning in nondemented patients with Parkinson's disease. |
000393 (2014) |
Marina Papoutsi [Royaume-Uni] ; Izelle Labuschagne ; Sarah J. Tabrizi ; Julie C. Stout | The cognitive burden in Huntington's disease: pathology, phenotype, and mechanisms of compensation. |
000502 (2014) |
Y T Asi [Royaume-Uni] ; Helen Ling ; Z. Ahmed ; A J Lees ; T. Revesz ; J L Holton | Neuropathological features of multiple system atrophy with cognitive impairment. |
000781 (2013) |
Alison J. Yarnall [Royaume-Uni] ; Lynn Rochester ; Mark R. Baker ; Rachel David ; Tien K. Khoo ; Gordan W. Duncan ; Brook Galna ; David J. Burn | Short latency afferent inhibition: a biomarker for mild cognitive impairment in Parkinson's disease? |
000923 (2013) |
Gordon W. Duncan [Royaume-Uni] ; Michael J. Firbank ; John T. O'Brien ; David J. Burn | Magnetic resonance imaging: a biomarker for cognitive impairment in Parkinson's disease? |
000E66 (2012) |
Mélanie Vendette [Canada] ; Jacques Montplaisir ; Nadia Gosselin ; Jean-Paul Soucy ; Ronald B. Postuma ; Thien Thanh Dang-Vu ; Jean-François Gagnon | Brain perfusion anomalies in rapid eye movement sleep behavior disorder with mild cognitive impairment. |
000E85 (2012) |
Simon J G. Lewis [Australie] ; James M. Shine ; Shantel Duffy ; Glenda Halliday ; Sharon L. Naismith | Anterior cingulate integrity: executive and neuropsychiatric features in Parkinson's disease. |
001282 (2011) |
Turi O. Dalaker [Norvège, États-Unis] ; Robert Zivadinov [États-Unis] ; Deepa Preeti Ramasamy [États-Unis] ; Mona K. Beyer [Norvège] ; Guido Alves [Norvège] ; Kolbjorn S. Bronnick [Norvège] ; Ole-Bjorn Tysnes [Norvège] ; Dag Aarsland [Norvège] ; Jan P. Larsen [Norvège] | Ventricular enlargement and mild cognitive impairment in early Parkinson's disease |
001C63 (2010) |
Turi O. Dalaker [États-Unis, Norvège] ; Robert Zivadinov [États-Unis] ; Jan P. Larsen [Norvège] ; Mona K. Beyer [Norvège] ; Jennifer L. Cox [États-Unis] ; Guido Alves [Norvège] ; Kolbjorn Bronnick [Norvège] ; Ole-Bjorn Tysnes [Norvège] ; Ronald Antulov [États-Unis, Croatie] ; Michael G. Dwyer [États-Unis] ; Dag Aarsland [Norvège] | Gray matter correlations of cognition in incident Parkinson's disease |
001D43 (2010) |
Norbert Brüggemann [Allemagne] ; Susanne A. Schneider [Allemagne] ; Thurid Sander [Allemagne] ; Christine Klein [Allemagne] ; Johann Hagenah [Allemagne] | Distinct basal ganglia hyperechogenicity in idiopathic basal ganglia calcification |
001D81 (2010) |
Flavio Nobili [Italie] ; Claudio Campus [Italie] ; Dario Arnaldi [Italie] ; Fabrizio De Carli [Italie] ; Gaia Cabassi [Italie] ; Andrea Brugnolo [Italie] ; Barbara Dessi [Italie] ; Silvia Morbelli [Italie] ; Gianmario Sambuceti [Italie] ; Giovanni Abbruzzese [Italie] ; Guido Rodriguez [Italie] | Cognitive‐nigrostriatal relationships in de novo, drug‐naïve Parkinson's disease patients: A [I‐123]FP‐CIT SPECT study |
001E56 (2010) |
Erin R. Foster [États-Unis] ; Meghan C. Campbell [États-Unis] ; Michelle A. Burack [États-Unis] ; Johanna Hartlein [États-Unis] ; Hubert P. Flores [États-Unis] ; Nigel J. Cairns [États-Unis] ; Tamara Hershey [États-Unis] ; Joel S. Perlmutter [États-Unis] | Amyloid imaging of Lewy body‐associated disorders |
002035 (2009) |
W. R. Wayne Martin [Canada] ; Marguerite Wieler [Canada] ; Myrlene Gee [Canada] ; Richard Camicioli [Canada] | Temporal lobe changes in early, untreated Parkinson's disease |
002222 (2009) |
Naroa Ibarretxe-Bilbao [Espagne] ; Eduardo Tolosa [Espagne] ; Carme Junque [Espagne] ; Maria-Jose Marti [Espagne] | MRI and cognitive impairment in Parkinson's disease |
002243 (2009) |
Bhaskara P. Shelley [Royaume-Uni] ; John R. Hodges [Royaume-Uni, Australie] ; Christopher M. Kipps [Royaume-Uni] ; John H. Xuereb [Royaume-Uni] ; Thomas H. Bak [Royaume-Uni] | Is the pathology of corticobasal syndrome predictable in life? |
002275 (2009) |
Maria C. Rodriguez-Oroz [Espagne] ; Pablo Martínez Lage [Espagne] ; Jose Sanchez-Mut [Espagne] ; Isabel Lamet [Espagne] ; Javier Pagonabarraga [Espagne] ; Jon B. Toledo [Espagne] ; David García-Garcia [Espagne] ; Pedro Clavero [Espagne] ; Lluis Samaranch [Espagne] ; Cecilia Irurzun [Espagne] ; Juan M. Matsubara [Espagne] ; Jaione Irigoien [Espagne] ; Emilia Bescos [Espagne] ; Jaime Kulisevsky [Espagne] ; Jordi Pérez-Tur [Espagne] ; Jose A. Obeso [Espagne] | Homocysteine and cognitive impairment in Parkinson's disease: A biochemical, neuroimaging, and genetic study |
002374 (2009) |
Inga Liepelt [Allemagne] ; Matthias Reimold [Allemagne] ; Walter Maetzler [Allemagne] ; Jana Godau [Allemagne] ; Gerald Reischl [Allemagne] ; Alexandra Gaenslen [Allemagne] ; Heinz Herbst [Allemagne] ; Daniela Berg [Allemagne] | Cortical hypometabolism assessed by a metabolic ratio in Parkinson's disease primarily reflects cognitive deterioration—[18F]FDG‐PET |
002375 (2009) |
Cristina Sanchez-Castaneda [Espagne] ; Ramon Rene [Espagne] ; Blanca Ramirez-Ruiz [Espagne] ; Jaume Campdelacreu [Espagne] ; Jordi Gascon [Espagne] ; Carles Falcon [Espagne] ; Matilde Calopa [Espagne] ; Serge Jauma [Espagne] ; Montserrat Juncadella [Espagne] ; Carme Junque [Espagne] | Correlations between gray matter reductions and cognitive deficits in dementia with Lewy Bodies and Parkinson's disease with dementia |
002F99 (2007) |
Shinji Ohara [Japon] ; Naoko Iijima [Japon] ; Kensuke Hayashida [Japon] ; Takashi Oide [Japon] ; Satoshi Katai [Japon] | Autopsy case of opsoclonus–myoclonus–ataxia and cerebellar cognitive affective syndrome associated with small cell carcinoma of the lung |
003307 (2006) |
Hui-Fang Shang [République populaire de Chine] ; Xiao-Feng Jiang [République populaire de Chine] ; Jean-Marc Burgunder [République populaire de Chine, Suisse] ; Qin Chen [République populaire de Chine] ; Dong Zhou [République populaire de Chine] | Novel mutation in the ceruloplasmin gene causing a cognitive and movement disorder with diabetes mellitus |
003A14 (2005) |
Anthony P. Nicholas [États-Unis] ; Kelly S. Earnst [États-Unis] ; Daniel C. Marson [États-Unis] | Atypical Hallervorden–Spatz disease with preserved cognition and obtrusive obsessions and compulsions |